VIBpharma is proud to announce the 3rd Annual Competitive Intelligence in Pharma conference taking place on April 13-14, 2010 in Philadelphia USA. Hailed as the largest gathering of CI professionals, delegates will have the opportunity to network with industry experts on gathering and safeguarding valuable information between divisions and share experiences on best practice strategies for ensuring your CI strategy holds up to new threats.

Register today at www.ciinpharma-events.com/usa2010 and reference code: ODD1

For more information, please email Melissa Fuentes, Event Planner, at events@arena-international.com, or alternatively telephone +44 (0)20 7753 4268 and mention the Competitive Intelligence in Pharma USA event

www.ciinpharma-events.com/usa2010

The meeting format this year includes:

• In-depth discussions of the developing issues surrounding aerosol drug delivery including new therapeutic opportunities and drug design technologies, progress in drug development alongside novel in vitro and in vivo testing methods, regulatory science..... and much more.
• Co-ordinated Workshop with the Product Quality Research Institute (PQRI) relating to the 'Role of Pharmacokinetics in Establishing Bioequivalence for Orally Inhaled Drug Products'. In 2010 Respiratory Drug Delivery (RDD) and PQRI will be collaborating to present both a Special Forum and follow-up Workshop to address the role of pharmacokinetics in establishing bioequivalence for orally inhaled drug products. The forum will take place on Thursday, April 29, 2010 as part of the RDD meeting, and the PQRI workshop will occur on Friday April 30. Both organisations hope that by collaborating, the maximum number of interested scientists in industry, government and academia will be able to join the debate about this important issue without having to travel to two locations
• Scientific Poster Session and Technology Exhibition in which device and equipment designers and component suppliers will present their latest developments alongside scientific posters from the aerosol community.
• Posters on the Podium where innovative poster abstracts will also be presented as short podium presentations during a special session in the main auditorium.
• Charles G. Thiel Award will be awarded to a scientist who has pioneered a significant development in the area of Respiratory Drug Delivery
• RDD 2010 Proceedings will be published and distributed to all registrants at no additional cost.

For more information, please Contact RDD Online

http://www.rddonline.com/rdd/rdd.php?id=5&sid=1

SMi’s 7th Controlled Release conference will provide you with the latest updates in this area, including controlled release development strategies, practical issues in developing controlled release products and information on the latest advances in delivery methods.

Key topics to be addressed at the conference include:

• The application of advanced science & technology to develop controlled release dosage forms
• Controlled Release - the role of intellectual property in maintaining and growing market share
• Overcoming the blood brain barrier
• Modified release multiparticulates
• Hot melt extrusion: How to enhance dissolution rate by solid dispersions
• Advanced biologic delivery systems

SPEAKER UPDATE: We are proud to announce that this year’s expert speakers include:

• Dr Paul Ashton, President & CEO, pSivida
• Professor Gregor Cevc, Chief Executive Officer, IDEA AG
• Alan Johnson, Partner, Bristows
• Dr Thomas Keller, Director - Biophysical Sensors & Nanomaterials PCD, GlaxoSmithKline
• Dr Vitaliy Khutoryanskiy, Lecturer in Pharmaceutics, University of Reading
• Dr Hassan Mohammad, Principal Scientist, Mundipharma International
• Dr Jens Uhlemann, Head of Product Design & Nanotechnology, Bayer Technology Services

Quote ONdrugDelivery and Receive a £100 discount –
Tel: +44 (0) 20 7827 6104

For more information, please visit us at
www.smi-online.co.uk/2010controlled19.asp

The RDD Europe 2011 meeting format will include:

• In-depth discussions of many developing issues surrounding aerosol drug delivery including new therapeutic opportunities and drug design technologies, progress in drug development alongside novel in vitro and in vivo testing methods, regulatory science..... and much more.
• Scientific Poster Sessions covering all aspects of regulatory science, formulation development, new research methods and advanced drug delivery technologies.
• Technology Exhibition in which excipient, device and equipment designers plus component and service suppliers present their latest developments in a table top format.
• Workshop Sessions featuring practical and interactive demonstrations of innovative technologies, products and services.

For more information, please Contact RDD Online

http://www.rddonline.com/rdd/rdd.php?id=5&sid=1